0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 301-320 of 1528 Articles
JAMA Surgery | 
Invited Commentary | 
L. Andrew DiFronzo, MD
JAMA Surg. 2014;149(2):154. doi:10.1001/jamasurg.2013.2719.

JAMA Dermatology | 
Case Report/Case Series | 
Rachel Kaplan, MSEd; Shane A. Meehan, MD; Marie Leger, MD, PhD
JAMA Dermatol. 2014;150(2):182-184. doi:10.1001/jamadermatol.2013.7371.

JAMA Internal Medicine | 
Original Investigation | 
Chin-Lin Tseng, DrPH; Orysya Soroka, MS; Miriam Maney, MA, CPHQ; et al.
JAMA Intern Med. 2014;174(2):259-268. doi:10.1001/jamainternmed.2013.12963.
Includes: Supplemental Content

JAMA Internal Medicine | 
Original Investigation | 
P. Michael Ho, MD, PhD; Anne Lambert-Kerzner, PhD, MSPH; Evan P. Carey, MS; et al.
JAMA Intern Med. 2014;174(2):186-193. doi:10.1001/jamainternmed.2013.12944.

JAMA | 
JAMA Revisited | 
JAMA. 2014;311(4):423. doi:10.1001/jama.2013.279299.

JAMA | 
Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(4):347-348. doi:10.1001/jama.2013.285704.

JAMA | 
Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(4):349. doi:10.1001/jama.2014.61.

JAMA | 
Original Investigation |  FREE
Leonard V. Sacks, MBBCh; Hala H. Shamsuddin, MD; Yuliya I. Yasinskaya, MD; et al.
JAMA. 2014;311(4):378-384. doi:10.1001/jama.2013.282542.
Includes: CME, Supplemental Content

JAMA | 
Users' Guides to the Medical Literature | 
Xin Sun, PhD; John P. A. Ioannidis, MD, DSc; Thomas Agoritsas, MD; et al.
JAMA. 2014;311(4):405-411. doi:10.1001/jama.2013.285063.
Includes: Supplemental Content

JAMA | 
Viewpoint | 
Benjamin Djulbegovic, MD, PhD; Iztok Hozo, PhD; John P. A. Ioannidis, MD, DSc
JAMA. 2014;311(4):355-356. doi:10.1001/jama.2013.283742.

JAMA | 
Viewpoint | 
Vinay Prasad, MD; Sham Mailankody, MB, BS
JAMA. 2014;311(4):353-354. doi:10.1001/jama.2013.284531.

JAMA | 
Original Investigation |  FREE
Stephen J. Nicholls, MBBS, PhD; John J. P. Kastelein, MD, PhD; Gregory G. Schwartz, MD, PhD; et al.
JAMA. 2014;311(3):252-262. doi:10.1001/jama.2013.282836.
Includes: Supplemental Content

JAMA | 
Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2014;311(3):233-234. doi:10.1001/jama.2013.284833.

JAMA | 
JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2014;311(3):321. doi:10.1001/jama.2013.283505.
Includes: Supplemental Content

JAMA | 
Global Health | 
M. J. Friedrich
JAMA. 2014;311(3):235. doi:10.1001/jama.2013.285742.

JAMA | 
Editorial | 
Gianna Zuccotti, MD; Edward H. Livingston, MD
JAMA. 2014;311(2):144. doi:10.1001/jama.2013.283819.

JAMA Ophthalmology | 
Original Investigation | 
Kerri P. Howard, MS; Barbara E. K. Klein, MD, MPH; Jennifer O. Dreyer, BS; et al.
JAMA Ophthalmol. 2014;132(1):23-31. doi:10.1001/jamaophthalmol.2013.6326.
Includes: Supplemental Content

JAMA | 
Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;311(1):19. doi:10.1001/jama.2013.285449.

JAMA | 
Viewpoint | 
Darius N. Lakdawalla, PhD; Anupam B. Jena, MD, PhD; Jason N. Doctor, PhD
JAMA. 2014;311(1):25-26. doi:10.1001/jama.2013.282839.

JAMA Internal Medicine | 
Research Letter | 
Ilke Sipahi, MD; Seden Celik, MD; Nurdan Tozun, MD
JAMA Intern Med. 2014;174(1):150-151. doi:10.1001/jamainternmed.2013.12217.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Internal Medicine
Invited Commentary  | 
Finding Meaningful Patterns in Adverse Drug Event Reports
Joshua J. Gagne, PharmD, ScD
JAMA Internal Medicine
Invited Commentary  | 
Dopamine Receptor Agonist Drugs and Impulse Control Disorders
Howard D. Weiss, MD; Gregory M. Pontone, MD
JAMA Internal Medicine
Original Investigation  | 
Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist Drugs
Thomas J. Moore, AB; Joseph Glenmullen, MD; Donald R. Mattison, MD, MS
JAMA Dermatology
Case Report/Case Series  | 
Drug-Associated Dermatomyositis Following Ipilimumab Therapy:  A Novel Immune-Mediated Adverse Event Associated With Cytotoxic T-Lymphocyte Antigen 4 Blockade
Shirwa Sheik Ali, BSc; Allison L. Goddard, MD; Jason J. Luke, MD; et al.